Investigators identified a chemokine/chemokine receptor mismatch for osteosarcoma (i.e., osteosarcomas secrete chemokines for which CAR T cells do not express receptors). The researchers modified CAR T cells targeting the osteosarcoma antigen B7-H3 to express CXCR2 or CXCR6 receptors, which recognize chemokines (CXCL8 or CXCL16) secreted by osteosarcoma.
Improved chemokine homing enhances CAR T–cell therapy for osteosarcoma
- Post author:
- Post published:August 5, 2024
- Post category:News Feed
- Post comments:0 Comments